FindTrial
Sign In

Survival of cirrhotic patients with different etiology after repeated endoscopic therapy for varices hemorrhage

Survival of cirrhotic patients with different etiology after repeated endoscopic therapy for varices hemorrhage

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800019265
Enrollment
Unknown
Registered
2018-11-02
Start date
2008-10-01
Completion date
Unknown
Last updated
2018-11-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

liver cirrhosis and gastroesophageal varices

Interventions

survival group versus death group:no

Sponsors

Beijing Ditan Hospital, Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
14 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1) Aged 14-75 years old male and female; 2) diagnosis of liver cirrhosis with esophageal and gastric variceal hemorrhage.

Exclusion criteria

Exclusion criteria: 1) patients with liver cancer or other malignant tumors; 2) patients with severe diseases of vital organs such as heart, lung, kidney, brain and blood affect their survival; 3) patients were treated with portal hypertension intervention such as TIPS splenectomy and splenectomy plus dissection; 4) patients with severe mental diseases; 5) pregnant and lactating women; 6) incomplete examination results of related clinical data.

Design outcomes

Primary

MeasureTime frame
survival time;—

Countries

China

Contacts

Public ContactHongsan Wei

Beijing Ditan Hospital, Capital Medical University

drwei@ccmu.edu.cn+86 13810033129

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026